Physician Assistant in West Wendover, NV Accepting Medicare
3 Physician Assistant nurses found. Showing 1 - 3
 Brock Lamont Vance, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 925 Wells Avenue, West Wendover, NV 89883 Phone: 775-664-2220 |
 Mrs. Christy Gene Somsen, P.A. - C Physician Assistant Medicare: Medicare Enrolled Practice Location: 925 Wells Ave, West Wendover, NV 89883 Phone: 775-664-2220 Fax: 775-664-2965 |
Daniel Jacob Densley, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 925 Wells Avenue, P.o. Box 3520, West Wendover, NV 89883 Phone: 775-664-2220 Fax: 775-664-2965 |
News Archive
New research reveals how maternal antibodies block immune response to measles virus
New research that reveals how maternal antibodies block an immune response to the measles virus is a first step toward improving current childhood vaccination practices, scientists say.
New York City mortality rate at all-time low in 2006
The death rate in New York City reached an all-time low in 2006, the Health Department reported today, as the number of deaths fell to 55,391 - down from 57,068 in 2005 and 60,218 in 2001.
Sleep quality in women with rheumatoid arthritis
According to a research abstract presented at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, symptoms of Rheumatoid Arthritis (RA) negatively affect women's sleep. Sleep is further impaired by pain, depression and poor adherence to RA medications.
FDA approves new drug for treatment of adults with chronic kidney disease
Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression.
Hawthorn announces licensing deal with University of Pittsburgh for novel monoclonal antibodies for cancer
Hawthorn Pharmaceuticals, Inc. today announced a global licensing deal with the University of Pittsburgh covering a series of novel monoclonal antibodies for cancer. The antibody portfolio targets a variety of cancers through the cell surface chondrotin sulfate proteoglycan 4 (CSPG4), which plays an important role in signaling pathways regulating tumor cell survival, growth, and motility.
› Verified 5 days ago